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Small bowel tumours are rare and originate from a wide variety of benign and malignant
entities. Adenocarcinomas are the most frequent primary malignant small bowel tumours.
Submucosal tumours like gastrointestinal stromal tumours (GIST) or neuroendocrine tumours
(NET) may show a central umbilication, pathologic vessels, bridging folds or an ulceration of
the overlying mucosa. These signs help to differentiate them from harmless bulges caused
by impression from outside, e.g. from other intestinal loops. Sarcomas of the small bowel are
rare neoplasias with mesenchymal origin, sometimes presenting as protruding masses. Benign
tumours like lipoma, ﬁbrolipoma, ﬁbroma, myoma, and heterotopias typically present as
submucosal masses. They cannot be differentiated endoscopically from those with malignant
potential as GIST or NET. Neuroendocrine carcinomas may present with diffuse inﬁltration,
which may resemble other malignant tumours. The endoscopic appearance of small bowel
lymphomas has a great variation from mass lesions to diffuse inﬁltrative changes. Melanoma
metastases are the most frequent metastases to the small bowel. They may be hard to
distinguish from other tumours when originating from an amelanotic melanoma.
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1. Backgrounds unNeoplastic lesions of the small bowel occur rarely with
predomination of benign tumours. Only 1–2% of all
gastrointestinal malignant tumours concern the small
bowel. Because of missing or unspeciﬁc early symptomsder CC BY-NC-ND license.
633Tumours in the Small Bowelsmall bowel tumours are often diagnosed in advanced
stage of disease. Capsule endoscopy can be helpful to detect small bowel
tumours earlier and affect the therapeutic course [1,2]. However, about 10–20% of small bowel tumours are
missed by capsule endoscopy. A combination with com-
puted tomography increases the diagnostic yield signiﬁ-
cantly [3]. Typical clinical presentation in earlier stages is overt or
occult midgastrointestinal bleeding. This applies to all
malignant entities, while lymphomas have the lowest
and gastrointestinal stromal tumours (GIST) the highest
incidence of bleeding. Benign tumours have an almost
equal bleeding potential with the exception of adenomas
and aberrant pancreatic tissue, who rarely present with
gastrointestinal bleeding [3]. Further unspeciﬁc symptoms are iron deﬁciency anaemia
of unknown origin, abdominal pain, weight loss and
partial or total intestinal obstruction. In these cases VCE may lead to the correct diagnosis
[4,5]. Balloon enteroscopy additionally enables biopsy,
haemostasis, palliative dilation or stenting. Submucosal tumours have to be differentiated from
harmless bulges due to impression from outside. Constant
size, discoloration, central umbilication, or bridging folds
are diagnostic hints for small bowel masses [6]. They
can be benign mesenchymal tumours or have malignant
potential like GIST and neuroendocrine tumours. Pathologic vessels may be a hint for malignancy, although
systematic data are missing. Ulceration of the overlying
mucosa may lead to midgastrointestinal bleeding [7]. Adenocarcinomas are the most common primary malig-
nant lesions of the small bowel. Approximately 50% of all
adenocarcimomas arise in the duodenum and can be
detected by upper endoscopy. They may appear as an
inﬁltrating or exophytic lesion with ulcerations or ste-
nosis [8]. Gastrointestinal stromal tumours (GIST) are the most
frequent malignant mesenchymal neoplasias of the small
bowel. Size and degree of proliferation are predictive
factors for malignancy. Endoscopic appearance is usually
a submucosal mass, sometimes with ulceration of the
mucosa. However, GISTs often show an eccentric extra-
luminal growth, leading to underestimation of the size by
endoscopy. Sarcomas are rare malignant mesenchymal tumours,
sometimes causing obstruction of the small bowel [9].
They may present as protruding masses, biopsy samples
lead to the diagnosis [10]. Lipomas are common benign submucosal tumours with a
typical soft, deformable consistence and shallow yellow
colour underneath normal mucosa. This colour is not as
striking as in more ﬂat, superﬁcial lymphatic cysts. Fibro-
lipomas are a rare histological variant of lipomas resulting
in a harder tissue. Ulcerations may cause bleeding. Neuroendocrine tumours (NET), which arise from enter-
ochromafﬁne cells, are often highly differentiated and
found incidentally. However, sometimes they may pre-
sent with bleeding or obstruction [3]. Mid-gut NETs are
preferably located in the appendix and ileum. Patients presenting with a carcinoid syndrome may suffer
from a NET of the small bowel with hepatic metastasis[11]. A complete small bowel examination via capsule
endoscopy should be considered in search of the primary
lesion. NET often present as submucosal tumours or multiple
submucosal nodules. It is not possible to clearly distin-
guish them from other entities as benign mesenchymal
neoplasias (e.g. myoma, ﬁbroma) heterotopias (e.g.
ectopic gastric or pancreatic mucosa), and potentially
malignant tumours as GIST. NET may occur as multifocal submucosal tumours [12].
When affecting the mesentery only, the tumour itself
may not be visible for capsule endoscopy. Red spots in a
short intestinal segment can be indirect signs. CT scan
may be helpful in these cases. Inﬁltrating neuroendocrine carcinomas cannot be differ-
entiated endoscopically from other malignant tumours.
Tissue sampling is required to clarify the subtype. Non-Hodgkin’s lymphomas of the small bowel show a
great endoscopic variation, sometimes presenting with
ulcerative, nodular or inﬁltrative changes, but some-
times only with diminutive mucosal changes like
erythema or lymphangiectasias [13]. A common endo-
scopic appearance is a ﬁrm, motionless mucosa. Perfora-
tion, obstruction and bleeding have been described as
well [14]. B-cell derived tumours account for the majority of small
bowel lymphomas, while enteropathy associated T-cell
lymphomas may develop as a complication of coeliac
disease. While the majority of small bowel malignancies are
primary lesions, some of them are of metastatic origin. Melanoma metastases are the most frequent metastatic
tumours found in the small bowel [15]. Their dark
pigmentation is diagnostic, while amelanotic types cannot
be distinguished endoscopically from other tumours [16]. Metastases from cancer of lung, breast, kidney, and other
malignancies have been described as well.2. Materials Video Capsule Endoscopes (PillCam SB1, PillCam SB2)
(Given Imaging, Yokneam, Israel; EndoCapsule 1 (Olympus,
Tokyo, Japan)) Gastroscopes GIF Q160 (Olympus Tokyo, Japan)
 Double-balloon Enteroscope EN 450-T5 (Fujinon, Tokyo,
Japan)
 Single-balloon Enteroscope SIF Q180 (Olympus, Tokyo,
Japan)3. Endoscopic procedure Small bowel Video Capsule Endoscopy (VCE)
 Gastroscopy
 Push Enteroscopy (PE)
 Single-balloon Enteroscopy (SBE)
 Double-balloon Enteroscopy (DBE)
N. Kurniawan et al.6344. Key learning points and tips and tricks4.1. Key learning points Small bowel tumours are rare and originate from a wide
variety of benign and malignant entities. Typical clinical presentation in earlier stage is overt or
occult midgastrointestinal bleeding. This applies to all
malignant entities [3]. Adenocarcinomas are the most common primary malig-
nant neoplastic lesions of the small bowel. Submucosal tumours like GIST or NET have to be differ-
entiated from harmless bulges. Central umbilication,
pathologic vessels or an ulceration of the overlying
mucosa are diagnostic hints for tumours. Lymphomas show a wide range of endoscopic ﬁndings,
from diminutive lesions to large masses. Melanomas are the most frequent metastases to the
small bowel.
4.2. Tips and Tricks In patients with recurrent GI bleeding in spite of normal
conventional and capsule endoscopy, imaging techniques
and balloon enteroscopy should be considered in the
search for tumour besides repeating upper and lower GI
endoscopy. Patients with mid-GI bleeding should be informed about
the low risk of capsule retention due to possibility of
underlying tumour. However, even in the unlikely event
of retention this has rather to be considered as diag-
nostic help. Hence, prior performance of Patency capsule
test in the absence of other risk factors is not helpful. In case of incidental diagnosis of an ileal NET, investiga-
tion of the entire small bowel might be considered, as
these tumours may be multifocal. However, the ther-
apeutic impact of this additional examination has yet to
be determined. Presence of mucosal discoloration, ulceration, umbilica-
tion, bridging folds, pathologic vessels on the surface,
constant form and sharp margins may be helpful to
distinguish submucosal tumours from harmless bulges at
capsule endoscopy. Tumours of the small bowel with extramural growth and
metastasis are preferably detected by imaging techni-
ques as CT scan and MRI, while endoscopic procedures
may detect small intraluminal lesions earlier. Therefore a
combination of radiological and endoscopic procedures is
recommended for diagnosis of small bowel tumours,
depending on clinical features and proliferation of the
tumour [3].
5. Complications and risk factors Small bowel tumours are a risk factor for capsule
retention [17]. However, capsule retention due to small
bowel tumour is still rare and rather considered adiagnostic aid than a complication.
 Suspected small bowel tumour as the indication for VCE
has a signiﬁcantly higher risk of retention, regardless of
the endoscopic ﬁnding [18]. Endoscopic polypectomy increases the risk of bleeding
and perforation during device-assisted enteroscopy.
Diagnosis of a tumour by tissue sampling and endoscopic
resection of tumours or polyps may cause bleeding or
perforation, DBE and SBE show overall complication rates
from app. 1% for diagnostic to 4% for therapeutic
procedures [19–21]. Diagnostic double balloon enteroscopy in patients with
diffuse small bowel lymphoma seams to bear a special
risk of perforation, especially if carried out after che-
motherapy [22]. Cases of small bowel tumours detected by double balloon
enteroscopy but missed by capsule endoscopy have been
reported [3,23].
6. Scripted voiceoverVoiceover Text
Small bowel tumours are rare, but are represented
by a wide range of different benign and malignant
entities.
Adenocarcinomas are the most frequent primary malignant
small bowel tumours. Partial obstruction of the lumen and
inﬁltration of the mucosa are typical ﬁndings.
Small bowel tumours often present as submucosal tumours,
as this gastrointestinal stromal tumour with ulceration of
the overlying mucosa
This submucosal GIST shows a constant form and a clear
boarder, differentiating it from a harmless bulge
The next capsule endoscopy shows a pedunculated and
bleeding ﬁbrolipoma of the jejunum. Histology cannot be
predicted by capsule endoscopy in these submucosal
tumours as ulceration of the overlying mucosa is also
observed in benign mesenchymal tumours
Push enteroscopy in this patient additionally demonstrates
the large ulceration of the mucosa.
Neuroendocrine tumors also typically present as submucosal
mass. This lesion shows a central umbilication.
Neuroendocrine tumors may appear multiple
In another case, inﬁltration of the mesentery by a
neuroendocrine tumor causes red spots of the small bowel
mucosa. Distribution to only one segment helps
differentiating these spots from multiple usual
angiectasias.
However, a diffusely inﬁltrating neuroendocrine carcinoma
may resemble any other malignant tumour. Here a large
ulcerated mass in the jejunum is seen during push
enteroscopy
Malignant melanoma is the most frequent origin of
metastases to the small bowel. Like in this capsule
endoscopy, the dark pigmentation is a key diagnostic
feature. However, it is not visible constantly. Other parts
of the tumour show unspeciﬁc ulceration or reddish,
swollen mucosa.
635Tumours in the Small BowelVoiceover Text
Amelanotic melanoma, however cannot be distinguished
endoscopically from other tumours like in this case,
where an ulcerated, inﬁltrating, and protruding mass of
the small bowel is seen
Non-Hodgkin’s lymphoma may involve the small bowel. The
endoscopic appearance of small bowel lymphomas has a
great variation. The next case of mantle cell lymphoma
causes diffuse inﬁltration of the proximal small bowel
with lymphangiectasia and erythema
In this patient with abdominal pain and mid GI bleeding
capsule endoscopy diagnosed a solid ulcerated tumour.
Stenosis lead to capsule retention as demonstrated by
double balloon enteroscopy. Surgical resection proofed an
isolated large B-cell lymphoma of the mid small bowel.
Sarcomas of the small bowel are rare tumours. Here a large
protruding and ulcerated mass is found in the proximal
small bowel of an elderly patient with overt bleeding.
Endoscopic appearance does not allow differention from
other tumours
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